Ernexa Therapeutics (ERNAW) Gains from Sales and Divestitures (2018 - 2025)
Ernexa Therapeutics (ERNAW) reported Gains from Sales and Divestitures of $1000.0 for Q4 2025, little changed on a YoY basis from $1000.0 in Q4 2024, and up 3233.33% quarter-over-quarter from $30.0 in Q3 2025.
Ernexa Therapeutics (ERNAW) Gains from Sales and Divestitures (2018 - 2025) Analysis & Trends
Ernexa Therapeutics has reported Gains from Sales and Divestitures for 8 years, with the latest figure at $1000.0 in Q4 2025.
- For the quarter ending Q4 2025, Gains from Sales and Divestitures changed 0.0% year-over-year to $1000.0; the trailing twelve-month figure through Dec 2025 stood at $1000.0 (changed 0.0% YoY), and the FY2025 full-year result was $1000.0, changed 0.0% from the prior year.
- Gains from Sales and Divestitures for Q4 2025 stood at $1000.0, up from $30.0 in the prior quarter.
- The five-year high for Gains from Sales and Divestitures was $31296.0 in Q1 2021, with the low at $29.0 in Q2 2024.
- Historically, Gains from Sales and Divestitures has averaged $3185.7 across 5 years, with a median of $1000.0 in 2022.
- Annual changes were most pronounced in 2024 — Gains from Sales and Divestitures sank 97.1% — and 2025, when it climbed 3.45%.
- Ernexa Therapeutics' Gains from Sales and Divestitures stood at $31296.0 in 2021, then tumbled by 90.41% to $3000.0 in 2022, then slumped by 66.67% to $1000.0 in 2023, then changed by 0.0% to $1000.0 in 2024, then changed by 0.0% to $1000.0 in 2025.
- The last three Gains from Sales and Divestitures figures came in at $1000.0 (Q4 2025), $30.0 (Q3 2025), and $30.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Ernexa Therapeutics | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1,000.00 |
| Dec 31, 2025 | 1,000.00 |
| Sep 30, 2025 | 30.00 |
| Sep 30, 2025 | 30.00 |
| Jun 30, 2025 | 30.00 |
| Jun 30, 2025 | 30.00 |
| Dec 31, 2024 | 1,000.00 |
| Dec 31, 2024 | 1,000.00 |
| Sep 30, 2024 | 29.00 |
| Sep 30, 2024 | 29.00 |
| Jun 30, 2024 | 29.00 |
| Jun 30, 2024 | 29.00 |
| Dec 31, 2023 | 1,000.00 |
| Dec 31, 2023 | 1,000.00 |
| Sep 30, 2023 | 1,000.00 |
| Sep 30, 2023 | 1,000.00 |
| Jun 30, 2023 | 1,000.00 |
| Jun 30, 2023 | 1,000.00 |
| Dec 31, 2022 | 3,000.00 |
| Dec 31, 2022 | 3,000.00 |